Please login to the form below

Not currently logged in
Email:
Password:

therapy watch

This page shows the latest therapy watch news and features for those working in and with pharma, biotech and healthcare.

New biosimilars group will tackle slow uptake in UK

New biosimilars group will tackle slow uptake in UK

Despite being around for several years in Europe, the awareness of biosimilars remains fairly low - with a survey carried out in 2014 by Therapy Watch finding just 8% of EU physicians

Latest news

  • Creating a brand identity for biosimilars Creating a brand identity for biosimilars

    Only 8 per cent of EU physicians spontaneously mentioned biosimilars as products in development in a recent survey by Therapy Watch, and only 35 per cent said they would definitely consider

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • The evolving biosimilars market The evolving biosimilars market

    Although these key regulatory developments are expected to greatly facilitate the approval of biosimilars in the near future, recent research from Research Partnership's Therapy Watch revealed that only 47% of

  • Pharma deals in April 2015 Pharma deals in April 2015

    Watch this space!  . Gene Therapy. After years of promise and failing to deliver, gene therapy companies are back in favour. ... No deal terms were disclosed. The initial development plan will look at the combination therapy as a potential treatment for

  • Biosimilars: friend or foe for healthcare systems? Biosimilars: friend or foe for healthcare systems?

    As the Therapy Watch data indicates, though, many believe the decision will ultimately be taken out of their hands. ... Fleetwood is director of Therapy Watch at the Research Partnership and can be contacted on tel: 44 208 0695049 or email her.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Research Partnership appoints new directors Research Partnership appoints new directors

    th. anniversary.”. “Having worked with Anne previously as a client of our syndicated market-tracking tool Therapy Watch, it’s great to now be able to welcome her to our

  • Helen Parfitt joins Research Partnership Helen Parfitt joins Research Partnership

    She takes on role as head of its Therapy Watch market tracking tool. ... I believe she will be a strong asset to the Therapy Watch team and we look forward to her contributing to its continued growth and development.”.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 13 fully matching, plus 15 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics